SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000920465-20-000109
Filing Date
2020-06-26
Accepted
2020-06-25 21:58:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A ljpc_schedule13dxa-tetraph.htm SC 13D/A 50111
  Complete submission text file 0000920465-20-000109.txt   51643
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filed by) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Subject) CIK: 0001373707 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87366 | Film No.: 20991028
SIC: 2834 Pharmaceutical Preparations